메뉴 건너뛰기




Volumn 33, Issue 2, 1997, Pages 123-129

Rimexolone: A new opthalmic corticosteroid with low intraocular pressure-raising potential

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE SODIUM PHOSPHATE; PREDNISOLONE ACETATE; RIMEXOLONE;

EID: 0030982308     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (5)

References (8)
  • 1
    • 84958107344 scopus 로고
    • Effects of hormone of adrenal cortex (17-hydroxy-11 dehydrocorticosterone: Compound E) and of the pituitary adrenocorticotropic hormone on rheumatoid arthritis
    • Hench, P.S., Kendall, E.L., Slocomb, C.H., Polley, H.F. Effects of hormone of adrenal cortex (17-hydroxy-11 dehydrocorticosterone: compound E) and of the pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin 1949, 24: 181.
    • (1949) Proc Staff Meet Mayo Clin , vol.24 , pp. 181
    • Hench, P.S.1    Kendall, E.L.2    Slocomb, C.H.3    Polley, H.F.4
  • 2
    • 0000915125 scopus 로고
    • Effects of pituitary adrenocorticotropic hormone (ACTH) therapy in ophthalmologic conditions
    • Gordon, D.M., McLean, J.M. Effects of pituitary adrenocorticotropic hormone (ACTH) therapy in ophthalmologic conditions. JAMA 1950, 142: 1271-5.
    • (1950) JAMA , vol.142 , pp. 1271-1275
    • Gordon, D.M.1    McLean, J.M.2
  • 3
    • 84878726893 scopus 로고
    • Protein-therapy induced hyperpyrexia
    • Williams & Wilkins: Baltimore
    • Woods, A.C. Protein-therapy induced hyperpyrexia. In: Endogenous Uveitis. Williams & Wilkins: Baltimore 1956, 234-8.
    • (1956) Endogenous Uveitis , pp. 234-238
    • Woods, A.C.1
  • 5
    • 84878745011 scopus 로고    scopus 로고
    • Technical data on file, Alcon Laboratories, Inc.
    • Technical data on file, Alcon Laboratories, Inc.
  • 6
    • 0029760607 scopus 로고    scopus 로고
    • Intraocular pressure-raising potential of 1% rimexolone in patients responding to corticosteroids
    • Leibowitz, H.M., Bartlett, J.D., Rich, R., McQuirter, H., Stewart, R., Assil, K. Intraocular pressure-raising potential of 1% rimexolone in patients responding to corticosteroids. Arch Ophthalmol 1996, 114: 933-7.
    • (1996) Arch Ophthalmol , vol.114 , pp. 933-937
    • Leibowitz, H.M.1    Bartlett, J.D.2    Rich, R.3    McQuirter, H.4    Stewart, R.5    Assil, K.6
  • 7
    • 9444291760 scopus 로고
    • Comparison of rimexolone 1% ophthalmic suspension to placebo in control of a postcataract surgery inflammation
    • Lehmann, R., Assil, K., Stewart R., Fox, K. Comparison of rimexolone 1% ophthalmic suspension to placebo in control of a postcataract surgery inflammation. Invest Ophthalmol Vis Sci 1995, 36 (4, Suppl.): 5793.
    • (1995) Invest Ophthalmol Vis Sci , vol.36 , Issue.4 SUPPL. , pp. 5793
    • Lehmann, R.1    Assil, K.2    Stewart, R.3    Fox, K.4
  • 8
    • 0029783542 scopus 로고    scopus 로고
    • Efficacy and safety of rimexolone 1% ophthalmic suspension vs 1% prednisolone acetate in the treatment of uveitis
    • Foster, C.S., Alter, G., DeBarge, L.R. et al. Efficacy and safety of rimexolone 1% ophthalmic suspension vs 1% prednisolone acetate in the treatment of uveitis. Am J Ophthalmol 1996, 122: 171-82.
    • (1996) Am J Ophthalmol , vol.122 , pp. 171-182
    • Foster, C.S.1    Alter, G.2    DeBarge, L.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.